Swedish Orphan Biovitrum Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 31 Oct 25 | SellSEK 22,955,100 | Guido Oelkers | Individual | 70,000 | SEK 327.93 | |
| 29 Oct 25 | SellSEK 18,913,686 | Torbjörn Hallberg | Individual | 58,230 | SEK 324.81 | |
| 29 Oct 25 | SellSEK 25,984,000 | Guido Oelkers | Individual | 80,000 | SEK 324.80 | |
| 28 Oct 25 | SellSEK 22,713,937 | Daniel Rankin | Individual | 69,920 | SEK 325.44 | |
| 24 Oct 25 | SellSEK 25,336,800 | Guido Oelkers | Individual | 80,000 | SEK 316.71 | |
| 23 Oct 25 | SellSEK 31,183,000 | Guido Oelkers | Individual | 100,000 | SEK 311.83 | |
| 22 Oct 25 | SellSEK 20,674,165 | Henrik Stenqvist | Individual | 65,835 | SEK 314.03 | |
| 22 Oct 25 | SellSEK 21,500,433 | Mahmood Ladha | Individual | 68,104 | SEK 315.70 | |
| 22 Oct 25 | SellSEK 17,679,805 | Lydia Abad-Franch | Individual | 56,026 | SEK 315.59 | |
| 21 Oct 25 | SellSEK 32,168,288 | Duane Barnes | Individual | 103,015 | SEK 312.27 | |
| 12 Aug 25 | BuySEK 24,778 | Katy Mazibuko | Individual | 90 | SEK 275.32 | |
| 29 Jul 25 | SellSEK 1,065,636 | Duane Barnes | Individual | 3,588 | SEK 297.00 | |
| 16 Jul 25 | SellSEK 2,227,882 | Sven Ullman | Individual | 7,723 | SEK 288.47 | |
| 10 Jun 25 | SellSEK 3,477,883 | Duane Barnes | Individual | 11,729 | SEK 296.52 | |
| 10 Jun 25 | SellSEK 2,168,727 | Mahmood Ladha | Individual | 7,314 | SEK 296.52 | |
| 10 Jun 25 | SellSEK 2,192,448 | Daniel Rankin | Individual | 7,394 | SEK 296.52 |
Insider Trading Volume
Insider Buying: SOBI insiders have only sold shares in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 1,045,837 | 0.303% |
| General Public | 54,177,950 | 15.7% |
| VC/PE Firms | 122,881,259 | 35.7% |
| Institutions | 166,551,254 | 48.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 122,881,259 | SEK 41.3b | 0% | 7.17% | |||
| 35,043,578 | SEK 11.8b | 0% | 0.12% | |||
| 20,763,106 | SEK 7.0b | 0% | 3.68% | |||
| 17,750,501 | SEK 6.0b | 0% | 1.48% | |||
| 11,766,573 | SEK 4.0b | 0% | 0.23% | |||
| 11,203,578 | SEK 3.8b | 0% | 0.05% | |||
| 8,795,907 | SEK 3.0b | 0% | 0.42% | |||
| 8,036,516 | SEK 2.7b | 0.25% | no data | |||
| 6,807,605 | SEK 2.3b | 0% | 0.71% | |||
| 6,156,665 | SEK 2.1b | 1.09% | no data | |||
| 5,185,539 | SEK 1.7b | 0% | 0.1% | |||
| 4,206,829 | SEK 1.4b | 0% | 0.74% | |||
| 3,412,411 | SEK 1.1b | 0% | 0.01% | |||
| 3,341,030 | SEK 1.1b | 0% | 0.96% | |||
| 2,636,857 | SEK 887.0m | 0% | 2.3% | |||
| 2,581,637 | SEK 868.5m | 0% | 0.16% | |||
| 2,156,703 | SEK 725.5m | 0% | 0.24% | |||
| 2,070,222 | SEK 696.4m | 0% | 0.05% | |||
| 1,542,416 | SEK 518.9m | 3.34% | no data | |||
| 1,270,236 | SEK 427.3m | 0% | 0.13% | |||
| 1,178,786 | SEK 396.5m | 0% | 0.16% | |||
| 1,097,716 | SEK 369.3m | 0% | 0.29% | |||
| 737,680 | SEK 248.2m | 1.52% | no data | |||
| 708,503 | SEK 238.3m | 0% | 0.01% | |||
| 694,307 | SEK 233.6m | 0% | 0.07% |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/24 22:24 |
| End of Day Share Price | 2025/11/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Swedish Orphan Biovitrum AB (publ) is covered by 28 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Xue Chen | Barclays |
| Rosie Turner | Barclays |